Pharmestro Lab A Catalyst for Growth in the Pharma Sector in Andhra Pradesh

Pharmestro Laboratories Private Limited's Bulk Drugs Manufacturing Unit Project in Gundlapalli, Prakasam, Andhra Pradesh, would boost the pharmaceutical sector. The project promotes harmony with environment on 2.41 acres, including 0.80 acres devoted to flora. The position combines closeness to human settlements like Annangi with 3.4 kilometers from Gundlapalli Village. It is bordered by unoccupied plots to the south and east, a road to the north, and an iron plant to the west. 

This sophisticated facility in Plot No. 539, APIIC Industrial Growth Centre, is 2.4 km from NH 5 Chennai-Visakhapatnam Highway and has great connectivity. A 49.5 TPM manufacturing facility produces bulk medicines and drug intermediates. Aceclofenac, Darunavir ethanolate, Favipiravir, Amisulpride, Apixaban, Rivaroxaban, Sitagliptin phosphate monohydrate, Linagliptin, Ondansetron hydrochloride dihydrate, Citalopram hydrobromide, Lopinavir, Ritonavir, Remdesvir, Escitalopram oxalate, Carvedilol, and others are planned. With an Environment Clearance from the Ministry of Environment, Forest, and Climate Change, this campaign emphasizes environmental awareness. 

The project follows all environmental laws, demonstrating Pharmestro Laboratories' commitment to responsible and sustainable production. Though still under progress, the initiative bodes well for the region's pharmaceutical industry. For more information about this pioneering endeavor, see the company's website or public sources.